Advertisement
CNO vs MET
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNO is a Hold and MET is a Hold.
CNO sees its Stochastic Oscillator ascending out of oversold territory
On October 05, 2026, the Stochastic Oscillator for CNO moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 53 instances where the indicator left the oversold zone. In 37 of the 53 cases the stock moved higher in the following days. This puts the odds of a move higher at over 70%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on CNO as a result. In 53 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
Following a +0.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNO advanced for three days, in 207 of 333 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
Bearish Trend Analysis
The 10-day RSI Indicator for CNO moved out of overbought territory on September 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In 23 of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at 59%.
The Moving Average Convergence Divergence Histogram (MACD) for CNO turned negative on September 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 15 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 33%.
CNO moved below its 50-day moving average on September 22, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CNO crossed bearishly below the 50-day moving average on September 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 4 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 27%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 47%.
The Aroon Indicator for CNO entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 2 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 4 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. CNO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.915) is normal, around the industry mean (1.355). P/E Ratio (18.497) is within average values for comparable stocks, (20.332). Projected Growth (PEG Ratio) (0.210) is also within normal values, averaging (0.463). Dividend Yield (0.013) settles around the average of (0.037) among similar stocks. P/S Ratio (1.156) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
MET in +2.36% Uptrend, advancing for three consecutive days on October 13, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MET advanced for three days, in 224 of 344 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on MET as a result. In 44 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 53%.
The Moving Average Convergence Divergence (MACD) for MET just turned positive on October 08, 2026. Looking at past instances where MET's MACD turned positive, the stock continued to rise in 31 of 52 cases over the following month. The odds of a continued upward trend are 60%.
MET moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MET crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
MET broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MET entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 29 (best 1 - 100 worst), indicating outstanding price growth. MET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MET's P/B Ratio (2.219) is slightly higher than the industry average of (1.355). P/E Ratio (18.356) is within average values for comparable stocks, (20.332). Projected Growth (PEG Ratio) (0.506) is also within normal values, averaging (0.463). Dividend Yield (0.024) settles around the average of (0.037) among similar stocks. P/S Ratio (0.824) is also within normal values, averaging (1.303).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
CNO | MET | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 18 | 34 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | 40 Fair valued | |
PROFIT vs RISK RATING 1..100 | 4 | 22 | |
SMR RATING 1..100 | 94 | 99 | |
PRICE GROWTH RATING 1..100 | 43 | 29 | |
P/E GROWTH RATING 1..100 | 17 | 16 | |
SEASONALITY SCORE 1..100 | 2 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MET's Valuation (40) in the Life Or Health Insurance industry is in the same range as CNO (50). This means that MET’s stock grew similarly to CNO’s over the last 12 months.
CNO's Profit vs Risk Rating (4) in the Life Or Health Insurance industry is in the same range as MET (22). This means that CNO’s stock grew similarly to MET’s over the last 12 months.
CNO's SMR Rating (94) in the Life Or Health Insurance industry is in the same range as MET (99). This means that CNO’s stock grew similarly to MET’s over the last 12 months.
MET's Price Growth Rating (29) in the Life Or Health Insurance industry is in the same range as CNO (43). This means that MET’s stock grew similarly to CNO’s over the last 12 months.
MET's P/E Growth Rating (16) in the Life Or Health Insurance industry is in the same range as CNO (17). This means that MET’s stock grew similarly to CNO’s over the last 12 months.
| CNO | MET | |
|---|---|---|
| RSI ODDS (%) | 7 days ago 59% | N/A |
| Stochastic ODDS (%) | 1 day ago 70% | 1 day ago 57% |
| Momentum ODDS (%) | 1 day ago 61% | 1 day ago 53% |
| MACD ODDS (%) | 3 days ago 33% | 1 day ago 60% |
| TrendWeek ODDS (%) | 1 day ago 47% | 1 day ago 59% |
| TrendMonth ODDS (%) | 1 day ago 44% | 1 day ago 54% |
| Advances ODDS (%) | 1 day ago 62% | 1 day ago 65% |
| Declines ODDS (%) | 15 days ago 47% | 15 days ago 52% |
| BollingerBands ODDS (%) | N/A | 1 day ago 56% |
| Aroon ODDS (%) | 1 day ago 44% | 1 day ago 43% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CNO’s FA Score shows that 2 FA rating(s) are green while MET’s FA Score has 3 green FA rating(s).
- CNO’s FA Score: 2 green, 3 red.
- MET’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CNO’s TA Score shows that 3 TA indicator(s) are bullish while MET’s TA Score has 5 bullish TA indicator(s).
- CNO’s TA Score: 3 bullish, 6 bearish.
- MET’s TA Score: 5 bullish, 4 bearish.
Price Growth
CNO (@Life/Health Insurance) experienced а -1.15% price change this week, while MET (@Life/Health Insurance) price change was +3.59% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was -2.23%. For the same industry, the average monthly price growth was -5.10%, and the average quarterly price growth was -3.03%.
Reported Earning Dates
CNO is expected to report earnings on Nov 04, 2026.
MET is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Life/Health Insurance (-2.23% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MSD | 6.71 | 0.02 | +0.30% |
| Morgan Stanley Emerging Markets Debt Fund | |||
| QCLN | 47.24 | 0.12 | +0.25% |
| First Trust Nasdaq Clean Edge Green Energy Index Fund (QCLN) | |||
| FEBM | 31.82 | -0.01 | -0.05% |
| FT Vest US Equity Max Buffer ETF-February (FEBM) | |||
| SATO | 17.20 | -0.08 | -0.45% |
| Invesco Alerian Galaxy Crypto Economy ETF (SATO) | |||
| TSLL | 10.00 | -0.15 | -1.48% |
| Direxion Daily TSLA Bull 2X ETF (TSLL) | |||
CNO and
Correlation & Price change
A.I.dvisor indicates that over the last year, CNO has been loosely correlated with LNC. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if CNO jumps, then LNC could also see price increases.
MET and
Correlation & Price change
A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.